Reviva Pharmaceuticals

$RVPH is up over 50% today as of now after announcing that its experimental drug to treat adults with schizophrenia met the main goal of a late-stage study. $6 looks to be an important resistance point as of now

Share this article:

About the Author:

Reviva Pharmaceuticals

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup